Pramipexole in Untreated and Levodopa-treated Parkinson's Disease Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objectives of this study were to evaluate the efficacy, safety, and tolerability of
pramipexole, as single-agent therapy or in combination with levodopa, in patients with
Parkinson disease living in Hong Kong and Taiwan.